Literature DB >> 8631205

Changes in GABA metabolism in streptozotocin-induced diabetic rat retinas.

A Ishikawa1, S Ishiguro, M Tamai.   

Abstract

We examined the pathogenesis of reduced amplitude in electroretinogram (ERG) oscillatory potentials (OPs) in diabetes, in relation to possible changes in the metabolisms involving retinal amino acid neurotransmitters. With use of streptozotocin diabetic rats, flash ERGs were recorded and quantitative analyses of retinal free amino acids were performed. Immunocytochemical localizations of retinal glycine and GABA were examined. In addition, activities of glutamic acid decarboxylase (GAD) and GABA transaminase (GABA-T) were measured. Our results revealed that the amplitudes of OP 1 and OP 2 decreased, and retinal glycine and GABA content significantly increased in the diabetic rats. An increased immunoreactivity of GABA was observed in Müller cells in the diabetic rat retinas, while no apparent changes were found in glycine immunoreactivity. Finally, increased activations of GAD with reduced activities of GABA-T were observed in the diabetic rat retinas. Thus, reduced amplitudes of OPs were associated with changes in content, localization, and enzyme activities related to GABA in the retinas, implying that changes in GABA metabolism can be a candidate for the pathogenesis of the abnormal OPs in diabetes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631205     DOI: 10.3109/02713689609017612

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  20 in total

Review 1.  Metabolomics in diabetic complications.

Authors:  Laura A Filla; James L Edwards
Journal:  Mol Biosyst       Date:  2016-02-19

2.  Identification of a novel neurotrophic factor from primary retinal Müller cells using stable isotope labeling by amino acids in cell culture (SILAC).

Authors:  Christine von Toerne; Jacob Menzler; Alice Ly; Nicole Senninger; Marius Ueffing; Stefanie M Hauck
Journal:  Mol Cell Proteomics       Date:  2014-06-12       Impact factor: 5.911

3.  The effects of vigabatrin on electrophysiology and visual fields in epileptics: a controlled study with a discussion of possible mechanisms.

Authors:  I F Comaish; C Gorman; G M Brimlow; C Barber; G M Orr; N R Galloway
Journal:  Doc Ophthalmol       Date:  2002-03       Impact factor: 2.379

4.  The effects of early diabetes on inner retinal neurons.

Authors:  Erika D Eggers; Teresia A Carreon
Journal:  Vis Neurosci       Date:  2020-09-16       Impact factor: 3.241

5.  Dietary taurine supplementation prevents glial alterations in retina of diabetic rats.

Authors:  Kaihong Zeng; Hongxia Xu; Mantian Mi; Qianyong Zhang; Yajie Zhang; Ka Chen; Fang Chen; Jundong Zhu; Xiaoping Yu
Journal:  Neurochem Res       Date:  2008-06-18       Impact factor: 3.996

6.  Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina.

Authors:  S-H Park; J-W Park; S-J Park; K-Y Kim; J-W Chung; M-H Chun; S-J Oh
Journal:  Diabetologia       Date:  2003-07-31       Impact factor: 10.122

7.  Streptozotocin-induced diabetes modulates GABA receptor activity of rat retinal neurons.

Authors:  David J Ramsey; Harris Ripps; Haohua Qian
Journal:  Exp Eye Res       Date:  2007-06-19       Impact factor: 3.467

8.  Rodent Hyperglycemia-Induced Inner Retinal Deficits are Mirrored in Human Diabetes.

Authors:  Machelle T Pardue; Claire S Barnes; Moon K Kim; Moe H Aung; Raj Amarnath; Darin E Olson; Peter M Thulé
Journal:  Transl Vis Sci Technol       Date:  2014-06-19       Impact factor: 3.283

9.  Functional implication of Dp71 in osmoregulation and vascular permeability of the retina.

Authors:  Abdoulaye Sene; Ramin Tadayoni; Thomas Pannicke; Antje Wurm; Brahim El Mathari; Romain Benard; Michel Joseph Roux; David Yaffe; Dominique Mornet; Andreas Reichenbach; Jose-Alain Sahel; Alvaro Rendon
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

10.  GABA and Glutamate Uptake and Metabolism in Retinal Glial (Müller) Cells.

Authors:  Andreas Bringmann; Antje Grosche; Thomas Pannicke; Andreas Reichenbach
Journal:  Front Endocrinol (Lausanne)       Date:  2013-04-17       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.